Digital Transformation (NASDAQ:DTOC) announced in an 8-K this morning that its shareholders approved its business combination with physician network American Oncology at a special meeting yesterday.
The two sides later announced they have closed the transaction and the combined company will begin trading on the Nasdaq under the symbol “AONC” on September 21.
The SPAC, which had already seen its trust heavily reduced in an extension vote, saw a further 1,699,558 shares redeemed at the meeting, leaving it with 147,511 remaining and a final redemption rate of 99.5%. This is the fourth highest redemption rate of 2023 behind Mount Rainier, Oxbridge and Decarbonization Plus IV.
Traders seeking a low float situation have noticed this and Digital Transformation hit a high of $31.87 earlier today.
This would leave Digital transformation with only about $1.5 million in its trust, but the deal’s $60 million minimum cash condition was waived in a June amendment. This tweak also saw the parties agree to sell 2,459 Class C units to an investor for $65 million.
Digital Transformation will still accept any decisions by shareholders to reverse their redemption decisions. But, otherwise the combined company is expected to trade on the Nasdaq under the symbol “AONC” once the transaction is closed.
The two sides initially announced their $497 million deal in October 2022. The Fort Myers, Florida-based company has gathered together a network of independent oncology practices in 18 states.
ADVISORS
- Paul Hastings LLP is serving as legal advisor to DTOC.
- Woolery & Co. PLLC and Dentons US LLP are serving as legal advisors to AON.


Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...